AMINOCAPROIC ACID
Aminocaproic Acid Tablets, USPRx only
Approved
Approval ID
871ec401-30f8-4154-a16e-b82dc1e04b49
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 20, 2023
Manufacturers
FDA
Carnegie Pharmaceuticals, LLC
DUNS: 079839141
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
AMINOCAPROIC ACID
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code80005-129
Application NumberANDA213928
Product Classification
M
Marketing Category
C73584
G
Generic Name
AMINOCAPROIC ACID
Product Specifications
Route of AdministrationORAL
Effective DateApril 20, 2023
FDA Product Classification
INGREDIENTS (5)
AMINOCAPROIC ACIDActive
Quantity: 1000 mg in 1 1
Code: U6F3787206
Classification: ACTIB
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
AMINOCAPROIC ACID
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code80005-128
Application NumberANDA213928
Product Classification
M
Marketing Category
C73584
G
Generic Name
AMINOCAPROIC ACID
Product Specifications
Route of AdministrationORAL
Effective DateApril 20, 2023
FDA Product Classification
INGREDIENTS (5)
AMINOCAPROIC ACIDActive
Quantity: 500 mg in 1 1
Code: U6F3787206
Classification: ACTIB
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT